Blood Flow Measurement Devices Market – Strategy Adopted by the players
The blood flow measurement devices market
 is projected to reach USD 533.0 Million by 2021 from USD 343.6 Million 
in 2016, growing at a CAGR of 9.2% in the next five years (2016 to 
2021).
Blood flow measurement devices are used to measure 
the volume rate of blood flow, which helps physicians to maintain 
equilibrium between blood supply and demand of tissue oxygen of 
patients. The measurement of blood flow helps in identifying blockages 
in the blood vessels and testing artificial blood vessels during organ 
transplantation, among others. These devices are imperative for 
diagnosing various clinical vascular conditions such as arterial 
occlusion, peripheral vascular diseases including diabetes, micro- and 
macro-vascular complications. The devices also find applications in skin
 testing, cerebral blood flow measurement, and burn assessment.
The major market players in the blood flow 
measurement devices market include Medistim ASA (Norway), Transonic 
Systems, Inc. (U.S.), Cook Medical, Inc. (U.S.), Moor Instruments Ltd. 
(U.K.), ADInstruments (Australia), SONOTEC Ultraschallsensorik Halle 
GmbH (Germany), Deltex Medical Group plc (U.K.), Atys Medical (France), 
Compumedics Ltd. (Australia), Perimed AB (Sweden), and BIOPAC Systems, 
Inc. (U.S.).
Product launches, product enhancements, and product 
extensions accounted for 42% of the total number of strategic 
developments undertaken by market players during 2013 to 2017 Players 
adopted this strategy to develop, commercialize, and expand their 
product & services portfolio, so as to strengthen their customer 
base and provide better access to their clients. The key players that 
adopted this strategy are Medistim ASA (Norway), SONOTEC 
Ultraschallsensorik Halle GmbH (Germany), Cook Medical, Inc. (U.S.), and
 ADInstruments (Australia).
Comments
Post a Comment